Literature DB >> 4372250

Profile of circulating vasoactive substances in hemorrhagic shock and their pharmacologic manipulation.

B A Jakschik, G R Marshall, J L Kourik, P Needleman.   

Abstract

(a) Hemorrhage in dogs (to 45-50 mm Hg) was associated with a 10-fold increase in plasma renin activity (PRA) which remained elevated throughout the time-course of shock including the irreversible (decompensation) stage. The presence of angiotensin II (AII) in arterial blood was demonstrated by the bloodbathed organ technique and confirmed by blockade with specific AII antagonists (cysteine(8)-AII or isoleucine(8)-AII). The contribution of AII to systemic peripheral resistance during hemorrhage shock in dogs was established by administering AII antagonists which immediately cause a further fall in blood pressure.(b) Plasma catecholamines (CA) steadily increased during hemorrhage and peaked during compensation (a 100-fold increase). The CA decreased progressively during decompensation.(c) Prostaglandin (PG) E-like material was observed in arterial blood for 15-60 min (after hemorrhage); the peak arterial concentration was 2.6 ng/ml blood. Indomethacin (i.v., before 80% of maximum bleedout): (i) confirmed the presence of PGE, (ii) increased blood pressure, and (iii) increased blood loss.(d) Thus: peripheral resistance during hemorrhagic shock seems temporally correlated with blood CA levels (and not PRA), and the renin-AII system contributes to the maintenance of vascular resistance and may markedly decrease perfusion of organs, such as kidney; the administration of the proper combination of specific antagonists of vasoconstrictor humoral substances may radically improve organ perfusion and could contribute to ultimate recovery from hemorrhagic shock.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4372250      PMCID: PMC301624          DOI: 10.1172/JCI107824

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  TRAUMATIC SHOCK. VI. THE EFFECT OF HEMORRHAGIC SHOCK ON THE CONCENTRATION OF RENIN AND HYPERTENSINOGEN IN THE PLASMA IN UNANESTHETIZED DOGS.

Authors:  L Dexter; H A Frank; F W Haynes; M D Altschule
Journal:  J Clin Invest       Date:  1943-11       Impact factor: 14.808

2.  Release of renal prostaglandin by catecholamines: relationship to renal endocrine function.

Authors:  P Needleman; J R Douglas; B Jakschik; P B Stoecklein; E M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1974-02       Impact factor: 4.030

3.  Proceedings: New dialysis technique for the continuous measurement of the concentration of vasoactive hormones.

Authors:  J G Collier
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

4.  A specific competitive inhibitor of angiotensin II.

Authors:  G R Marshall; W Vine; P Needlemann
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

5.  The relative effect of the renal pressor and sympathetic nervous systems on vascular capacity during hypotension.

Authors:  D W DuCharme; L Beck
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

6.  Control by prostaglandin E2 of sympathetic neurotrans-mission in the spleen.

Authors:  P Hedqvist
Journal:  Life Sci       Date:  1970-03-01       Impact factor: 5.037

7.  Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

Authors:  P J Piper; J R Vane
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

8.  Prostaglandins released by the spleen.

Authors:  N Gilmore; J R Vane; J H Wyllie
Journal:  Nature       Date:  1968-06-22       Impact factor: 49.962

9.  Neural stimulation of release of renin.

Authors:  R D Bunag; I H Page; J W McCubbin
Journal:  Circ Res       Date:  1966-10       Impact factor: 17.367

10.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  14 in total

1.  Shock and the kidney: pathophysiology and pharmacological support.

Authors:  C B Brown
Journal:  Intensive Care Med       Date:  1977-04       Impact factor: 17.440

2.  Beneficial and detrimental actions of histamine H1- and H2-receptor antagonists in circulatory shock.

Authors:  B M Altura; S Halevy
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  Glycogen phosphorylase, glucose output and vasoconstriction in the perfused rat liver. Concentration-dependence of actions of adrenaline, vasopressin and angiotensin II.

Authors:  D A Hems; L M Rodrigues; P D Whitton
Journal:  Biochem J       Date:  1976-11-15       Impact factor: 3.857

4.  High salt diet impairs cerebral blood flow regulation via salt-induced angiotensin II suppression.

Authors:  Linda A Allen; James R Schmidt; Christopher T Thompson; Brian E Carlson; Daniel A Beard; Julian H Lombard
Journal:  Microcirculation       Date:  2019-01-15       Impact factor: 2.628

Review 5.  Heart failure in experimental refractory shock.

Authors:  I M Ledingham
Journal:  Eur J Intensive Care Med       Date:  1976-11

6.  Cardiac and hepatic metabolism in spontaneously hypertensive rats following acute blood loss.

Authors:  S Kashimoto; A Nonaka; T Nakamura; T Yamaguchi; T Kumazawa
Journal:  J Anesth       Date:  1992-07       Impact factor: 2.078

7.  Renal failure in haemorrhagic shock in dogs: salutary effects of the calcium entry blocker felodipine.

Authors:  M S Chintala; B S Jandhyala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

8.  Suppression of prostanoid formation and regulation of peripheral circulation after surgery using thrombin inhibitor (MD805).

Authors:  M Onizuka; S Ishikawa; O Ishibashi; M Suga; K Mitsui; T Mitsui
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

9.  Mechanisms of renin secretion during hemorrhage in the dog.

Authors:  W L Henrich; R W Schrier; T Berl
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

10.  Urinary kallikrein excretion during inhibition of endogenous angiotensin II in the pig.

Authors:  B R Binder; M Maier; H Rana; M Starlinger; Z Zhegu
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.